Tradestie Institutional Equity Comparison Engine
EVMN vs AGMB โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EVMN Overall Edge
EVMN Captures Institutional Edge (3โ0 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Evommune, Inc. (EVMN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, EVMN trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus AGMB at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, EVMN sits in SURGE (53rd %ile IV; Dealer Gamma Walls on Pro) against AGMB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
EVMN N/M vs AGMB N/M Fwd P/E
Growth & Margin Winner
EVMN
Op Margin 0.0% vs N/A ยท YoY +0.0% vs N/A
Momentum & Technical Winner
EVMN
1Y -61.0% vs -59.2% ยท 52W Pos 8% vs 2%
Options & Structure Winner
EVMN
SURGE (53rd %ile IV) vs UNCLASSIFIED (N/A IV)
EVMN
US Equity
Evommune, Inc.
Pharmaceutical Preparations
$7.10
-6.95% 1D
Market Cap
$315.5M
1M Return
+37.33%
1Y Return
-61.03%
Forward P/E
N/M
Unified AI Score
30.0 / 100
SELL
Tech 50.0
Fund 35.0
Flow 69.0
Mom 44.0
AGMB
US Equity
AGMB
Institutional Equity
$5.97
-6.13% 1D
Market Cap
N/A
1M Return
-27.9%
1Y Return
-59.25%
Forward P/E
N/M
Unified AI Score
40.9 / 100
SELL
Tech 25.0
Fund 43.0
Flow 50.0
Mom 59.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
EVMN -61.03%
AGMB -59.25%
Spread: +0.27 pp (EVMN Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
EVMN TTM Op. Margin: 0.0%
AGMB TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EVMN vs AGMB. Trailing 12-month operating profitability (EVMN 0.0% vs AGMB N/A) and valuation multiples (EVMN N/M vs AGMB N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EVMN | AGMB | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $315.5M | N/A | Larger Scale | EVMN |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | N/A | Higher Growth | EVMN |
| Operating Margin (TTM) Profitability | 0.0% | N/A | Higher Margin | EVMN |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | EVMN |
| Return on Equity (ROE) Capital Efficiency | -69.5% | N/A | Higher ROE | EVMN |
| 52-Week Range Position Momentum | 8% ($5โ$33) | 2% ($6โ$18) | Stronger Trend | EVMN |
| Beta / 30D Volatility Risk Regime | 1.05ฮฒ ยท 118% Vol | 1.44ฮฒ ยท 78% Vol | Lower Realized Risk | AGMB |
| Unified Institutional Score Composite Signal | 30.0 / 100 (SELL) | 40.9 / 100 (SELL) | Higher Composite | AGMB |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full EVMN vs AGMB Buy Guide
EVMN
SURGE
5d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
53rd %ile
IV Regime
Balanced (25thโ60th %ile)
AGMB
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither EVMN nor AGMB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.